AG
RDY icon

Ascent Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Ascent Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Sell
10,828
-3,289
-23% -$44.4K ﹤0.01% 787
2026
Q1 		$196K Buy
+14,117
New +$197K 0.01% 730
2025
Q3 		– Sell
-10,885
Closed -$164K – 773
2025
Q2 		$164K Buy
10,885
+754
+7% +$10.8K 0.01% 703
2025
Q1 		$134K Buy
+10,131
New +$140K 0.01% 681

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ascent Group's RDY Position: Q2 2026 in Review

Ascent Group reduced its Dr. Reddy's Laboratories (RDY) stake by 23% in Q2 2026, selling an estimated $44.4K and leaving 10,828 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Ascent Group first reported a position in RDY in Q1 2025 and has held it in 4 quarters since. The position peaked at $196K in Q1 2026. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Ascent Group held 10,828 shares of Dr. Reddy's Laboratories worth $157K as of Q2 2026.
  • Ascent Group sold 3,289 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $44.4K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Ascent Group's portfolio in Q2 2026, its #787 holding.
  • Ascent Group first reported a position in Dr. Reddy's Laboratories in Q1 2025 and has held it in 4 quarters since.
  • Ascent Group's Dr. Reddy's Laboratories position peaked at $196K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.